Lance C. Pagliaro
Mayo Clinic(US)WinnMed(US)Mayo Clinic in Arizona(US)
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Renal cell carcinoma treatment, Genital Health and Disease, Bladder and Urothelial Cancer Treatments, Urologic and reproductive health conditions
Most-Cited Works
- → Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials(2019)815 cited
- → Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology(2020)623 cited
- → Platinum-Based Chemotherapy for Variant Castrate-Resistant Prostate Cancer(2013)460 cited
- → Phase I Trial of the Proteasome Inhibitor Bortezomib in Patients With Advanced Solid Tumors With Observations in Androgen-Independent Prostate Cancer(2004)437 cited
- → Bone-targeted therapy for advanced androgen-independent carcinoma of the prostate: a randomised phase II trial(2001)395 cited
- → Neoadjuvant Paclitaxel, Ifosfamide, and Cisplatin Chemotherapy for Metastatic Penile Cancer: A Phase II Study(2010)389 cited